Cargando…

Preferential use of Siglec-1 or Siglec-10 by type 1 and type 2 PRRSV strains to infect PK15(S1–CD163) and PK15(S10–CD163) cells

Cellular entry mediators define whether the cell is permissive to PRRSV infection. Porcine sialoadhesin (pSn, Siglec-1) and CD163 are main entry mediators facilitating infection of porcine macrophages by PRRSV. Recently, Siglec-10 was demonstrated to be an alternative receptor for PRRSV. To examine...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jiexiong, Christiaens, Isaura, Yang, Bo, Trus, Ivan, Devriendt, Bert, Cui, Tingting, Wei, Ruifang, Nauwynck, Hans J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052533/
https://www.ncbi.nlm.nih.gov/pubmed/30021620
http://dx.doi.org/10.1186/s13567-018-0569-z
_version_ 1783340673243545600
author Xie, Jiexiong
Christiaens, Isaura
Yang, Bo
Trus, Ivan
Devriendt, Bert
Cui, Tingting
Wei, Ruifang
Nauwynck, Hans J.
author_facet Xie, Jiexiong
Christiaens, Isaura
Yang, Bo
Trus, Ivan
Devriendt, Bert
Cui, Tingting
Wei, Ruifang
Nauwynck, Hans J.
author_sort Xie, Jiexiong
collection PubMed
description Cellular entry mediators define whether the cell is permissive to PRRSV infection. Porcine sialoadhesin (pSn, Siglec-1) and CD163 are main entry mediators facilitating infection of porcine macrophages by PRRSV. Recently, Siglec-10 was demonstrated to be an alternative receptor for PRRSV. To examine if virulence and pathogenicity of PRRSV strains could be correlated with the use of different Siglecs, a PK15 cell line recombinantly expressing Siglec-1 and CD163 (PK15(S1–CD163)) and a PK15 cell line recombinantly expressing Siglec-10 and CD163 (PK15(S10–CD163)) were used to compare the virus replication of 7 genotype 1 subtype 1 strains (G1s1), 2 genotype 1 subtype 3 (G1s3) strains and 5 genotype 2 (G2) strains. Some strains (08VA (G1s1), 13V117 (G1s1), 17V035 (G1s1), VR2332 (G2)) were poor virus producers (<10(4) TCID(50)/mL), while other strains (07V063 (G1s1), 13V091 (G1s1), Su1-Bel (G1s3), MN-184 (G2), Korea17 (G2) and SDSU-73 (G2)) easily grew up to ≥10(6) TCID(50)/mL. PK15(S10–CD163) cells exhibited a higher efficiency in virus production per infected cell than the PK15(S1–CD163) cells. The G1s1 strains LV and 07V063 infected more cells in the PK15(S1–CD163), whereas the 94V360 and 08VA strains preferred PK15(S10–CD163). The highly virulent G1s3 strains Lena and Su1-Bel showed a strong preference for PK15(S1–CD163). The G2 strains MN-184, SDSU-73, Korea17 had a much higher infection rate in PK15(S10–CD163), while the reference strain VR2332 and the NADC30 strain had a slight preference for PK15(S1–CD163). Differences in receptor use may influence the outcome of a PRRSV infection in pigs and explain in part the virulence/pathogenicity of PRRSV strains. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13567-018-0569-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6052533
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60525332018-07-20 Preferential use of Siglec-1 or Siglec-10 by type 1 and type 2 PRRSV strains to infect PK15(S1–CD163) and PK15(S10–CD163) cells Xie, Jiexiong Christiaens, Isaura Yang, Bo Trus, Ivan Devriendt, Bert Cui, Tingting Wei, Ruifang Nauwynck, Hans J. Vet Res Research Article Cellular entry mediators define whether the cell is permissive to PRRSV infection. Porcine sialoadhesin (pSn, Siglec-1) and CD163 are main entry mediators facilitating infection of porcine macrophages by PRRSV. Recently, Siglec-10 was demonstrated to be an alternative receptor for PRRSV. To examine if virulence and pathogenicity of PRRSV strains could be correlated with the use of different Siglecs, a PK15 cell line recombinantly expressing Siglec-1 and CD163 (PK15(S1–CD163)) and a PK15 cell line recombinantly expressing Siglec-10 and CD163 (PK15(S10–CD163)) were used to compare the virus replication of 7 genotype 1 subtype 1 strains (G1s1), 2 genotype 1 subtype 3 (G1s3) strains and 5 genotype 2 (G2) strains. Some strains (08VA (G1s1), 13V117 (G1s1), 17V035 (G1s1), VR2332 (G2)) were poor virus producers (<10(4) TCID(50)/mL), while other strains (07V063 (G1s1), 13V091 (G1s1), Su1-Bel (G1s3), MN-184 (G2), Korea17 (G2) and SDSU-73 (G2)) easily grew up to ≥10(6) TCID(50)/mL. PK15(S10–CD163) cells exhibited a higher efficiency in virus production per infected cell than the PK15(S1–CD163) cells. The G1s1 strains LV and 07V063 infected more cells in the PK15(S1–CD163), whereas the 94V360 and 08VA strains preferred PK15(S10–CD163). The highly virulent G1s3 strains Lena and Su1-Bel showed a strong preference for PK15(S1–CD163). The G2 strains MN-184, SDSU-73, Korea17 had a much higher infection rate in PK15(S10–CD163), while the reference strain VR2332 and the NADC30 strain had a slight preference for PK15(S1–CD163). Differences in receptor use may influence the outcome of a PRRSV infection in pigs and explain in part the virulence/pathogenicity of PRRSV strains. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13567-018-0569-z) contains supplementary material, which is available to authorized users. BioMed Central 2018-07-18 2018 /pmc/articles/PMC6052533/ /pubmed/30021620 http://dx.doi.org/10.1186/s13567-018-0569-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Xie, Jiexiong
Christiaens, Isaura
Yang, Bo
Trus, Ivan
Devriendt, Bert
Cui, Tingting
Wei, Ruifang
Nauwynck, Hans J.
Preferential use of Siglec-1 or Siglec-10 by type 1 and type 2 PRRSV strains to infect PK15(S1–CD163) and PK15(S10–CD163) cells
title Preferential use of Siglec-1 or Siglec-10 by type 1 and type 2 PRRSV strains to infect PK15(S1–CD163) and PK15(S10–CD163) cells
title_full Preferential use of Siglec-1 or Siglec-10 by type 1 and type 2 PRRSV strains to infect PK15(S1–CD163) and PK15(S10–CD163) cells
title_fullStr Preferential use of Siglec-1 or Siglec-10 by type 1 and type 2 PRRSV strains to infect PK15(S1–CD163) and PK15(S10–CD163) cells
title_full_unstemmed Preferential use of Siglec-1 or Siglec-10 by type 1 and type 2 PRRSV strains to infect PK15(S1–CD163) and PK15(S10–CD163) cells
title_short Preferential use of Siglec-1 or Siglec-10 by type 1 and type 2 PRRSV strains to infect PK15(S1–CD163) and PK15(S10–CD163) cells
title_sort preferential use of siglec-1 or siglec-10 by type 1 and type 2 prrsv strains to infect pk15(s1–cd163) and pk15(s10–cd163) cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052533/
https://www.ncbi.nlm.nih.gov/pubmed/30021620
http://dx.doi.org/10.1186/s13567-018-0569-z
work_keys_str_mv AT xiejiexiong preferentialuseofsiglec1orsiglec10bytype1andtype2prrsvstrainstoinfectpk15s1cd163andpk15s10cd163cells
AT christiaensisaura preferentialuseofsiglec1orsiglec10bytype1andtype2prrsvstrainstoinfectpk15s1cd163andpk15s10cd163cells
AT yangbo preferentialuseofsiglec1orsiglec10bytype1andtype2prrsvstrainstoinfectpk15s1cd163andpk15s10cd163cells
AT trusivan preferentialuseofsiglec1orsiglec10bytype1andtype2prrsvstrainstoinfectpk15s1cd163andpk15s10cd163cells
AT devriendtbert preferentialuseofsiglec1orsiglec10bytype1andtype2prrsvstrainstoinfectpk15s1cd163andpk15s10cd163cells
AT cuitingting preferentialuseofsiglec1orsiglec10bytype1andtype2prrsvstrainstoinfectpk15s1cd163andpk15s10cd163cells
AT weiruifang preferentialuseofsiglec1orsiglec10bytype1andtype2prrsvstrainstoinfectpk15s1cd163andpk15s10cd163cells
AT nauwynckhansj preferentialuseofsiglec1orsiglec10bytype1andtype2prrsvstrainstoinfectpk15s1cd163andpk15s10cd163cells